In 2024, SIA Novartis Baltics had revenue of 95.1 million EUR and profit of 2.9 million EUR. The company has 40 employees.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 95,1m € +9.5% | 86,9m € +12.3% | 77,4m € +8.8% |
Profit | 2,9m € +14460.1% | -20,3k € -101.0% | 2m € -46.3% |
Assets | 41,3m € +12.6% | 36,7m € -13.8% | 42,5m € +45.8% |
Liabilities | 33,4m € +5.4% | 31,7m € +20.7% | 26,3m € +76.6% |
Equity | 7,8m € +59.0% | 4,9m € -69.6% | 16,2m € +13.7% |
Employees | 98 +0.0% | 98 -16.2% | 117 -1.7% |
Overall rating | A+95/100 |
Financial health | 100/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 70/100 |
| Overall risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | Independently | |||
| - | Board member | Independently | |||
| Board member | Independently |
SIA Novartis Baltics is located at Rīga, Skanstes iela 25, LV-1013.
In 2024, SIA Novartis Baltics had revenue of 95 145 326 EUR and profit of 2 912 811 EUR. Compared to previous year, revenue increased by 9.5%. View full financial report →
In 2024, SIA Novartis Baltics had an average of 40 employees. View tax history →
Yes, SIA Novartis Baltics is registered as an active VAT payer with VAT number LV40203071239.
In 2024, the average gross salary at SIA Novartis Baltics was approximately 5997,48 € per month (net ~ 4129,02 €). This is an approximate calculation. View salary details →
SIA Novartis Baltics was founded on May 24, 2017. The company has been operating for 9 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 9 years | 210 - 214 | 21% | |
Net revenue | 95 145 326,00 € | 2 - 6 | 99% | |
Profit | 2 912 811,00 € | 7 - 11 | 97% | |
Equity | 7 847 438,00 € | 16 - 20 | 92% | |
Assets | 41 285 185,00 € | 4 - 8 | 98% | |
Fixed assets | 260 254,00 € | - | 90% | |
Investments | 697 500,00 € | - | 90% | |
Liquidity | 1.21 | - | 40% | |
Profitability | 3.1% | - | 10% | |
Registered capital | 3 000 000,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.
| Name, surname | Shares | Ownership rights |
|---|---|---|
| Novartis Pharma AG | 3000 | 100.00% |